🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate the efficacy and safety of AK104 plus concurrent ...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2022-06-21
Trial ID
NCT05235516
This is A Randomized, Double-blind, Placebo-controlled Phase III Study to E...
Status
Active Not Recruiting
Location
Women's Hospital School Of Medicine Zhejiang University
Start Date
2021-08-27
Trial ID
NCT04982237
Treatments Being Tested
A study to evaluate cadonilimab (AK104) + lenvatinib in combination with tr...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2024-08-02
Trial ID
NCT06371157
Treatments Being Tested
A randomized, Double-blind, Multicenter, phase III Clinical Study of Compar...
Status
Completed
Location
Peking University Cancer Hospital
Start Date
2021-09-17
Trial ID
NCT05008783
The efficacy and safety of AK104 as adjuvant therapy in hepatocellular carc...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2023-01-05
Trial ID
NCT05489289
To compare whether AK104 combined with GP or PFLL can improve survival bene...
Status
Recruiting
Location
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center
Start Date
2024-02-01
Trial ID
NCT06241599
Treatments Being Tested